DRL is an international CRO and R&D company with a biobank of more than 30K cases across different diseases. We offer flexible customizable solutions for clinical and preclinical studies to reduce the costs of drug discovery. Our services include but are not limited to:

- Biospecimen procurement (fresh/frozen tissue, FFPE, RNA, DNA, protein, etc.) from a wide range of disease histologies and DNA mutations (including custom requests);
- Phase 0 platform for human testing of therapeutics;
- Tumor organoid pharmacology assays to test lead/candidate therapeutics (these models are better predictors of anti-tumor activity than 2D or xenograft-based models);
- Development of custom 3D assays for in vitro studies or other applications based on client needs (eg, oncology).